0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Recombinant Proteins Market Research Report 2026
Published Date: 2026-02-27
|
Report Code: QYRE-Auto-34G8837
Home | Market Reports
Global Recombinant Proteins Market Size Status and Forecast 2022
BUY CHAPTERS

Global Recombinant Proteins Market Research Report 2026

Code: QYRE-Auto-34G8837
Report
2026-02-27
Pages:120
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Recombinant Proteins Market Size

The global Recombinant Proteins market was valued at US$ 1390 million in 2025 and is anticipated to reach US$ 3236 million by 2032, at a CAGR of 13.0% from 2026 to 2032.

Recombinant Proteins Market

Recombinant Proteins Market

Recombinant protein is a manipulated form of protein encoded by recombinant DNA, which has been cloned in a foreign expression system to supports the expression of the exogenous gene. This recombinant DNA construct can be used to manufacture large quantities of useful protein products. The recombinant DNA, usually the cDNA sequence of the target protein, is designed to be under the control of a well-characterized promoter to express the target protein within the chosen host cell to achieve high-level protein expression.
Global key manufacturers of recombinant proteins are Bio-Techne Corporation, Abcam PLC, Merck KGaA, Miltenyi Biotec, Thermo Fisher Scientific, ACROBiosystems, Sino Biological, and others. The top six manufacturers together account for about 50% of the market share, with the largest manufacturer being Bio-Techne Corporation with 10%. In terms of market size, Asia Pacific is the largest consumption market with more than 35% share. In terms of product categories, cytokines hold the largest market share with 25%, followed by hormones and immune checkpoint regulators with 20% and 15% respectively. In terms of applications, biopharmaceutical companies are the top application area, with over 80% of the market share.
This report delivers a comprehensive overview of the global Recombinant Proteins market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Recombinant Proteins. The Recombinant Proteins market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Recombinant Proteins market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Recombinant Proteins manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Recombinant Proteins Market Report

Report Metric Details
Report Name Recombinant Proteins Market
Accounted market size in 2025 US$ 1390 million
Forecasted market size in 2032 US$ 3236 million
CAGR 13.0%
Base Year 2025
Forecasted years 2026 - 2032
Segment by Type
  • Hormones
  • Growth Factors
  • Cytokines
  • Plasma Protein Factor
  • Recombinant Metabolic Enzymes
  • Immune Checkpoint Regulators
  • Others
Segment by Application
  • Biopharmaceutical Companies
  • Academic and Research Institutes
  • Contract Research Organizations
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Bio-Techne Corporation, Abcam PLC, Merck KGaA, Miltenyi Biotec, Thermo Fisher Scientific, ACROBiosystems, Sino Biological, Cytiva, Eurogentec, GenScript Biotech Corporation, Reprocell, BPS Bioscience, Abnova Corporation, ProSpec Tany TechnoGene, Ajinomoto
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
  • Chapter 3: Provides a detailed view of the competitive landscape for Recombinant Proteins companies, covering revenue share, development plans, and mergers and acquisitions.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
  • Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
  • Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
  • Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
  • Chapter 12: Key findings and conclusions of the report.

FAQ for this report

How fast is Recombinant Proteins Market growing?

Ans: The Recombinant Proteins Market witnessing a CAGR of 13.0% during the forecast period 2026-2032.

What is the Recombinant Proteins Market size in 2032?

Ans: The Recombinant Proteins Market size in 2032 will be US$ 3236 million.

What is the market share of major companies in Recombinant Proteins Market?

Ans: The top six manufacturers together account for about 50% of the market share, with the largest manufacturer being Bio-Techne Corporation with 10%.

What is the Recombinant Proteins Market share by region?

Ans: In terms of market size, Asia Pacific is the largest consumption market with more than 35% share.

What is the Recombinant Proteins Market share by type?

Ans: In terms of product categories, cytokines hold the largest market share with 25%, followed by hormones and immune checkpoint regulators with 20% and 15% respectively.

Who are the main players in the Recombinant Proteins Market report?

Ans: The main players in the Recombinant Proteins Market are Bio-Techne Corporation, Abcam PLC, Merck KGaA, Miltenyi Biotec, Thermo Fisher Scientific, ACROBiosystems, Sino Biological, Cytiva, Eurogentec, GenScript Biotech Corporation, Reprocell, BPS Bioscience, Abnova Corporation, ProSpec Tany TechnoGene, Ajinomoto

What are the Application segmentation covered in the Recombinant Proteins Market report?

Ans: The Applications covered in the Recombinant Proteins Market report are Biopharmaceutical Companies, Academic and Research Institutes, Contract Research Organizations

What are the Type segmentation covered in the Recombinant Proteins Market report?

Ans: The Types covered in the Recombinant Proteins Market report are Hormones, Growth Factors, Cytokines, Plasma Protein Factor, Recombinant Metabolic Enzymes, Immune Checkpoint Regulators, Others

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Recombinant Proteins Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Hormones
1.2.3 Growth Factors
1.2.4 Cytokines
1.2.5 Plasma Protein Factor
1.2.6 Recombinant Metabolic Enzymes
1.2.7 Immune Checkpoint Regulators
1.2.8 Others
1.3 Market by Application
1.3.1 Global Recombinant Proteins Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Biopharmaceutical Companies
1.3.3 Academic and Research Institutes
1.3.4 Contract Research Organizations
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Recombinant Proteins Market Perspective (2021–2032)
2.2 Global Recombinant Proteins Growth Trends by Region
2.2.1 Global Recombinant Proteins Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Recombinant Proteins Historic Market Size by Region (2021–2026)
2.2.3 Recombinant Proteins Forecasted Market Size by Region (2027–2032)
2.3 Recombinant Proteins Market Dynamics
2.3.1 Recombinant Proteins Industry Trends
2.3.2 Recombinant Proteins Market Drivers
2.3.3 Recombinant Proteins Market Challenges
2.3.4 Recombinant Proteins Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Recombinant Proteins Players by Revenue
3.1.1 Global Top Recombinant Proteins Players by Revenue (2021–2026)
3.1.2 Global Recombinant Proteins Revenue Market Share by Players (2021–2026)
3.2 Global Top Recombinant Proteins Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Recombinant Proteins Revenue
3.4 Global Recombinant Proteins Market Concentration Ratio
3.4.1 Global Recombinant Proteins Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Recombinant Proteins Revenue in 2025
3.5 Global Key Players of Recombinant Proteins Head Offices and Areas Served
3.6 Global Key Players of Recombinant Proteins, Products and Applications
3.7 Global Key Players of Recombinant Proteins, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Recombinant Proteins Breakdown Data by Type
4.1 Global Recombinant Proteins Historic Market Size by Type (2021–2026)
4.2 Global Recombinant Proteins Forecasted Market Size by Type (2027–2032)
5 Recombinant Proteins Breakdown Data by Application
5.1 Global Recombinant Proteins Historic Market Size by Application (2021–2026)
5.2 Global Recombinant Proteins Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Recombinant Proteins Market Size (2021–2032)
6.2 North America Recombinant Proteins Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Recombinant Proteins Market Size by Country (2021–2026)
6.4 North America Recombinant Proteins Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Recombinant Proteins Market Size (2021–2032)
7.2 Europe Recombinant Proteins Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Recombinant Proteins Market Size by Country (2021–2026)
7.4 Europe Recombinant Proteins Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Recombinant Proteins Market Size (2021–2032)
8.2 Asia-Pacific Recombinant Proteins Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Recombinant Proteins Market Size by Region (2021–2026)
8.4 Asia-Pacific Recombinant Proteins Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Recombinant Proteins Market Size (2021–2032)
9.2 Latin America Recombinant Proteins Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Recombinant Proteins Market Size by Country (2021–2026)
9.4 Latin America Recombinant Proteins Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Recombinant Proteins Market Size (2021–2032)
10.2 Middle East & Africa Recombinant Proteins Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Recombinant Proteins Market Size by Country (2021–2026)
10.4 Middle East & Africa Recombinant Proteins Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Bio-Techne Corporation
11.1.1 Bio-Techne Corporation Company Details
11.1.2 Bio-Techne Corporation Business Overview
11.1.3 Bio-Techne Corporation Recombinant Proteins Introduction
11.1.4 Bio-Techne Corporation Revenue in Recombinant Proteins Business (2021–2026)
11.1.5 Bio-Techne Corporation Recent Development
11.2 Abcam PLC
11.2.1 Abcam PLC Company Details
11.2.2 Abcam PLC Business Overview
11.2.3 Abcam PLC Recombinant Proteins Introduction
11.2.4 Abcam PLC Revenue in Recombinant Proteins Business (2021–2026)
11.2.5 Abcam PLC Recent Development
11.3 Merck KGaA
11.3.1 Merck KGaA Company Details
11.3.2 Merck KGaA Business Overview
11.3.3 Merck KGaA Recombinant Proteins Introduction
11.3.4 Merck KGaA Revenue in Recombinant Proteins Business (2021–2026)
11.3.5 Merck KGaA Recent Development
11.4 Miltenyi Biotec
11.4.1 Miltenyi Biotec Company Details
11.4.2 Miltenyi Biotec Business Overview
11.4.3 Miltenyi Biotec Recombinant Proteins Introduction
11.4.4 Miltenyi Biotec Revenue in Recombinant Proteins Business (2021–2026)
11.4.5 Miltenyi Biotec Recent Development
11.5 Thermo Fisher Scientific
11.5.1 Thermo Fisher Scientific Company Details
11.5.2 Thermo Fisher Scientific Business Overview
11.5.3 Thermo Fisher Scientific Recombinant Proteins Introduction
11.5.4 Thermo Fisher Scientific Revenue in Recombinant Proteins Business (2021–2026)
11.5.5 Thermo Fisher Scientific Recent Development
11.6 ACROBiosystems
11.6.1 ACROBiosystems Company Details
11.6.2 ACROBiosystems Business Overview
11.6.3 ACROBiosystems Recombinant Proteins Introduction
11.6.4 ACROBiosystems Revenue in Recombinant Proteins Business (2021–2026)
11.6.5 ACROBiosystems Recent Development
11.7 Sino Biological
11.7.1 Sino Biological Company Details
11.7.2 Sino Biological Business Overview
11.7.3 Sino Biological Recombinant Proteins Introduction
11.7.4 Sino Biological Revenue in Recombinant Proteins Business (2021–2026)
11.7.5 Sino Biological Recent Development
11.8 Cytiva
11.8.1 Cytiva Company Details
11.8.2 Cytiva Business Overview
11.8.3 Cytiva Recombinant Proteins Introduction
11.8.4 Cytiva Revenue in Recombinant Proteins Business (2021–2026)
11.8.5 Cytiva Recent Development
11.9 Eurogentec
11.9.1 Eurogentec Company Details
11.9.2 Eurogentec Business Overview
11.9.3 Eurogentec Recombinant Proteins Introduction
11.9.4 Eurogentec Revenue in Recombinant Proteins Business (2021–2026)
11.9.5 Eurogentec Recent Development
11.10 GenScript Biotech Corporation
11.10.1 GenScript Biotech Corporation Company Details
11.10.2 GenScript Biotech Corporation Business Overview
11.10.3 GenScript Biotech Corporation Recombinant Proteins Introduction
11.10.4 GenScript Biotech Corporation Revenue in Recombinant Proteins Business (2021–2026)
11.10.5 GenScript Biotech Corporation Recent Development
11.11 Reprocell
11.11.1 Reprocell Company Details
11.11.2 Reprocell Business Overview
11.11.3 Reprocell Recombinant Proteins Introduction
11.11.4 Reprocell Revenue in Recombinant Proteins Business (2021–2026)
11.11.5 Reprocell Recent Development
11.12 BPS Bioscience
11.12.1 BPS Bioscience Company Details
11.12.2 BPS Bioscience Business Overview
11.12.3 BPS Bioscience Recombinant Proteins Introduction
11.12.4 BPS Bioscience Revenue in Recombinant Proteins Business (2021–2026)
11.12.5 BPS Bioscience Recent Development
11.13 Abnova Corporation
11.13.1 Abnova Corporation Company Details
11.13.2 Abnova Corporation Business Overview
11.13.3 Abnova Corporation Recombinant Proteins Introduction
11.13.4 Abnova Corporation Revenue in Recombinant Proteins Business (2021–2026)
11.13.5 Abnova Corporation Recent Development
11.14 ProSpec Tany TechnoGene
11.14.1 ProSpec Tany TechnoGene Company Details
11.14.2 ProSpec Tany TechnoGene Business Overview
11.14.3 ProSpec Tany TechnoGene Recombinant Proteins Introduction
11.14.4 ProSpec Tany TechnoGene Revenue in Recombinant Proteins Business (2021–2026)
11.14.5 ProSpec Tany TechnoGene Recent Development
11.15 Ajinomoto
11.15.1 Ajinomoto Company Details
11.15.2 Ajinomoto Business Overview
11.15.3 Ajinomoto Recombinant Proteins Introduction
11.15.4 Ajinomoto Revenue in Recombinant Proteins Business (2021–2026)
11.15.5 Ajinomoto Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Recombinant Proteins Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
 Table 2. Key Players of Hormones
 Table 3. Key Players of Growth Factors
 Table 4. Key Players of Cytokines
 Table 5. Key Players of Plasma Protein Factor
 Table 6. Key Players of Recombinant Metabolic Enzymes
 Table 7. Key Players of Immune Checkpoint Regulators
 Table 8. Key Players of Others
 Table 9. Global Recombinant Proteins Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
 Table 10. Global Recombinant Proteins Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 11. Global Recombinant Proteins Market Size by Region (US$ Million), 2021–2026
 Table 12. Global Recombinant Proteins Market Share by Region (2021–2026)
 Table 13. Global Recombinant Proteins Forecasted Market Size by Region (US$ Million), 2027–2032
 Table 14. Global Recombinant Proteins Market Share by Region (2027–2032)
 Table 15. Recombinant Proteins Market Trends
 Table 16. Recombinant Proteins Market Drivers
 Table 17. Recombinant Proteins Market Challenges
 Table 18. Recombinant Proteins Market Restraints
 Table 19. Global Recombinant Proteins Revenue by Players (US$ Million), 2021–2026
 Table 20. Global Recombinant Proteins Market Share by Players (2021–2026)
 Table 21. Global Top Recombinant Proteins Players by Tier (Tier 1, Tier 2, and Tier 3), based on Recombinant Proteins Revenue, 2025
 Table 22. Ranking of Global Top Recombinant Proteins Companies by Revenue (US$ Million) in 2025
 Table 23. Global 5 Largest Players Market Share by Recombinant Proteins Revenue (CR5 and HHI), 2021–2026
 Table 24. Global Key Players of Recombinant Proteins, Headquarters and Area Served
 Table 25. Global Key Players of Recombinant Proteins, Products and Applications
 Table 26. Global Key Players of Recombinant Proteins, Date of General Availability (GA)
 Table 27. Mergers and Acquisitions, Expansion Plans
 Table 28. Global Recombinant Proteins Market Size by Type (US$ Million), 2021–2026
 Table 29. Global Recombinant Proteins Revenue Market Share by Type (2021–2026)
 Table 30. Global Recombinant Proteins Forecasted Market Size by Type (US$ Million), 2027–2032
 Table 31. Global Recombinant Proteins Revenue Market Share by Type (2027–2032)
 Table 32. Global Recombinant Proteins Market Size by Application (US$ Million), 2021–2026
 Table 33. Global Recombinant Proteins Revenue Market Share by Application (2021–2026)
 Table 34. Global Recombinant Proteins Forecasted Market Size by Application (US$ Million), 2027–2032
 Table 35. Global Recombinant Proteins Revenue Market Share by Application (2027–2032)
 Table 36. North America Recombinant Proteins Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 37. North America Recombinant Proteins Market Size by Country (US$ Million), 2021–2026
 Table 38. North America Recombinant Proteins Market Size by Country (US$ Million), 2027–2032
 Table 39. Europe Recombinant Proteins Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 40. Europe Recombinant Proteins Market Size by Country (US$ Million), 2021–2026
 Table 41. Europe Recombinant Proteins Market Size by Country (US$ Million), 2027–2032
 Table 42. Asia-Pacific Recombinant Proteins Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 43. Asia-Pacific Recombinant Proteins Market Size by Region (US$ Million), 2021–2026
 Table 44. Asia-Pacific Recombinant Proteins Market Size by Region (US$ Million), 2027–2032
 Table 45. Latin America Recombinant Proteins Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 46. Latin America Recombinant Proteins Market Size by Country (US$ Million), 2021–2026
 Table 47. Latin America Recombinant Proteins Market Size by Country (US$ Million), 2027–2032
 Table 48. Middle East & Africa Recombinant Proteins Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 49. Middle East & Africa Recombinant Proteins Market Size by Country (US$ Million), 2021–2026
 Table 50. Middle East & Africa Recombinant Proteins Market Size by Country (US$ Million), 2027–2032
 Table 51. Bio-Techne Corporation Company Details
 Table 52. Bio-Techne Corporation Business Overview
 Table 53. Bio-Techne Corporation Recombinant Proteins Product
 Table 54. Bio-Techne Corporation Revenue in Recombinant Proteins Business (US$ Million), 2021–2026
 Table 55. Bio-Techne Corporation Recent Development
 Table 56. Abcam PLC Company Details
 Table 57. Abcam PLC Business Overview
 Table 58. Abcam PLC Recombinant Proteins Product
 Table 59. Abcam PLC Revenue in Recombinant Proteins Business (US$ Million), 2021–2026
 Table 60. Abcam PLC Recent Development
 Table 61. Merck KGaA Company Details
 Table 62. Merck KGaA Business Overview
 Table 63. Merck KGaA Recombinant Proteins Product
 Table 64. Merck KGaA Revenue in Recombinant Proteins Business (US$ Million), 2021–2026
 Table 65. Merck KGaA Recent Development
 Table 66. Miltenyi Biotec Company Details
 Table 67. Miltenyi Biotec Business Overview
 Table 68. Miltenyi Biotec Recombinant Proteins Product
 Table 69. Miltenyi Biotec Revenue in Recombinant Proteins Business (US$ Million), 2021–2026
 Table 70. Miltenyi Biotec Recent Development
 Table 71. Thermo Fisher Scientific Company Details
 Table 72. Thermo Fisher Scientific Business Overview
 Table 73. Thermo Fisher Scientific Recombinant Proteins Product
 Table 74. Thermo Fisher Scientific Revenue in Recombinant Proteins Business (US$ Million), 2021–2026
 Table 75. Thermo Fisher Scientific Recent Development
 Table 76. ACROBiosystems Company Details
 Table 77. ACROBiosystems Business Overview
 Table 78. ACROBiosystems Recombinant Proteins Product
 Table 79. ACROBiosystems Revenue in Recombinant Proteins Business (US$ Million), 2021–2026
 Table 80. ACROBiosystems Recent Development
 Table 81. Sino Biological Company Details
 Table 82. Sino Biological Business Overview
 Table 83. Sino Biological Recombinant Proteins Product
 Table 84. Sino Biological Revenue in Recombinant Proteins Business (US$ Million), 2021–2026
 Table 85. Sino Biological Recent Development
 Table 86. Cytiva Company Details
 Table 87. Cytiva Business Overview
 Table 88. Cytiva Recombinant Proteins Product
 Table 89. Cytiva Revenue in Recombinant Proteins Business (US$ Million), 2021–2026
 Table 90. Cytiva Recent Development
 Table 91. Eurogentec Company Details
 Table 92. Eurogentec Business Overview
 Table 93. Eurogentec Recombinant Proteins Product
 Table 94. Eurogentec Revenue in Recombinant Proteins Business (US$ Million), 2021–2026
 Table 95. Eurogentec Recent Development
 Table 96. GenScript Biotech Corporation Company Details
 Table 97. GenScript Biotech Corporation Business Overview
 Table 98. GenScript Biotech Corporation Recombinant Proteins Product
 Table 99. GenScript Biotech Corporation Revenue in Recombinant Proteins Business (US$ Million), 2021–2026
 Table 100. GenScript Biotech Corporation Recent Development
 Table 101. Reprocell Company Details
 Table 102. Reprocell Business Overview
 Table 103. Reprocell Recombinant Proteins Product
 Table 104. Reprocell Revenue in Recombinant Proteins Business (US$ Million), 2021–2026
 Table 105. Reprocell Recent Development
 Table 106. BPS Bioscience Company Details
 Table 107. BPS Bioscience Business Overview
 Table 108. BPS Bioscience Recombinant Proteins Product
 Table 109. BPS Bioscience Revenue in Recombinant Proteins Business (US$ Million), 2021–2026
 Table 110. BPS Bioscience Recent Development
 Table 111. Abnova Corporation Company Details
 Table 112. Abnova Corporation Business Overview
 Table 113. Abnova Corporation Recombinant Proteins Product
 Table 114. Abnova Corporation Revenue in Recombinant Proteins Business (US$ Million), 2021–2026
 Table 115. Abnova Corporation Recent Development
 Table 116. ProSpec Tany TechnoGene Company Details
 Table 117. ProSpec Tany TechnoGene Business Overview
 Table 118. ProSpec Tany TechnoGene Recombinant Proteins Product
 Table 119. ProSpec Tany TechnoGene Revenue in Recombinant Proteins Business (US$ Million), 2021–2026
 Table 120. ProSpec Tany TechnoGene Recent Development
 Table 121. Ajinomoto Company Details
 Table 122. Ajinomoto Business Overview
 Table 123. Ajinomoto Recombinant Proteins Product
 Table 124. Ajinomoto Revenue in Recombinant Proteins Business (US$ Million), 2021–2026
 Table 125. Ajinomoto Recent Development
 Table 126. Research Programs/Design for This Report
 Table 127. Key Data Information from Secondary Sources
 Table 128. Key Data Information from Primary Sources
 Table 129. Authors List of This Report


List of Figures
 Figure 1. Recombinant Proteins Picture
 Figure 2. Global Recombinant Proteins Market Size Comparison by Type (US$ Million), 2021–2032
 Figure 3. Global Recombinant Proteins Market Share by Type: 2025 vs 2032
 Figure 4. Hormones Features
 Figure 5. Growth Factors Features
 Figure 6. Cytokines Features
 Figure 7. Plasma Protein Factor Features
 Figure 8. Recombinant Metabolic Enzymes Features
 Figure 9. Immune Checkpoint Regulators Features
 Figure 10. Others Features
 Figure 11. Global Recombinant Proteins Market Size by Application (US$ Million), 2021–2032
 Figure 12. Global Recombinant Proteins Market Share by Application: 2025 vs 2032
 Figure 13. Biopharmaceutical Companies Case Studies
 Figure 14. Academic and Research Institutes Case Studies
 Figure 15. Contract Research Organizations Case Studies
 Figure 16. Recombinant Proteins Report Years Considered
 Figure 17. Global Recombinant Proteins Market Size (US$ Million), Year-over-Year: 2021–2032
 Figure 18. Global Recombinant Proteins Market Size, (US$ Million), 2021 vs 2025 vs 2032
 Figure 19. Global Recombinant Proteins Market Share by Region: 2025 vs 2032
 Figure 20. Global Recombinant Proteins Market Share by Players in 2025
 Figure 21. Global Recombinant Proteins Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
 Figure 22. The Top 10 and 5 Players Market Share by Recombinant Proteins Revenue in 2025
 Figure 23. North America Recombinant Proteins Market Size YoY Growth (US$ Million), 2021–2032
 Figure 24. North America Recombinant Proteins Market Share by Country (2021–2032)
 Figure 25. United States Recombinant Proteins Market Size YoY Growth (US$ Million), 2021–2032
 Figure 26. Canada Recombinant Proteins Market Size YoY Growth (US$ Million), 2021–2032
 Figure 27. Europe Recombinant Proteins Market Size YoY Growth (US$ Million), 2021–2032
 Figure 28. Europe Recombinant Proteins Market Share by Country (2021–2032)
 Figure 29. Germany Recombinant Proteins Market Size YoY Growth (US$ Million), 2021–2032
 Figure 30. France Recombinant Proteins Market Size YoY Growth (US$ Million), 2021–2032
 Figure 31. U.K. Recombinant Proteins Market Size YoY Growth (US$ Million), 2021–2032
 Figure 32. Italy Recombinant Proteins Market Size YoY Growth (US$ Million), 2021–2032
 Figure 33. Russia Recombinant Proteins Market Size YoY Growth (US$ Million), 2021–2032
 Figure 34. Ireland Recombinant Proteins Market Size YoY Growth (US$ Million), 2021–2032
 Figure 35. Asia-Pacific Recombinant Proteins Market Size YoY Growth (US$ Million), 2021–2032
 Figure 36. Asia-Pacific Recombinant Proteins Market Share by Region (2021–2032)
 Figure 37. China Recombinant Proteins Market Size YoY Growth (US$ Million), 2021–2032
 Figure 38. Japan Recombinant Proteins Market Size YoY Growth (US$ Million), 2021–2032
 Figure 39. South Korea Recombinant Proteins Market Size YoY Growth (US$ Million), 2021–2032
 Figure 40. Southeast Asia Recombinant Proteins Market Size YoY Growth (US$ Million), 2021–2032
 Figure 41. India Recombinant Proteins Market Size YoY Growth (US$ Million), 2021–2032
 Figure 42. Australia & New Zealand Recombinant Proteins Market Size YoY Growth (US$ Million), 2021–2032
 Figure 43. Latin America Recombinant Proteins Market Size YoY Growth (US$ Million), 2021–2032
 Figure 44. Latin America Recombinant Proteins Market Share by Country (2021–2032)
 Figure 45. Mexico Recombinant Proteins Market Size YoY Growth (US$ Million), 2021–2032
 Figure 46. Brazil Recombinant Proteins Market Size YoY Growth (US$ Million), 2021–2032
 Figure 47. Middle East & Africa Recombinant Proteins Market Size YoY Growth (US$ Million), 2021–2032
 Figure 48. Middle East & Africa Recombinant Proteins Market Share by Country (2021–2032)
 Figure 49. Israel Recombinant Proteins Market Size YoY Growth (US$ Million), 2021–2032
 Figure 50. Saudi Arabia Recombinant Proteins Market Size YoY Growth (US$ Million), 2021–2032
 Figure 51. UAE Recombinant Proteins Market Size YoY Growth (US$ Million), 2021–2032
 Figure 52. Bio-Techne Corporation Revenue Growth Rate in Recombinant Proteins Business (2021–2026)
 Figure 53. Abcam PLC Revenue Growth Rate in Recombinant Proteins Business (2021–2026)
 Figure 54. Merck KGaA Revenue Growth Rate in Recombinant Proteins Business (2021–2026)
 Figure 55. Miltenyi Biotec Revenue Growth Rate in Recombinant Proteins Business (2021–2026)
 Figure 56. Thermo Fisher Scientific Revenue Growth Rate in Recombinant Proteins Business (2021–2026)
 Figure 57. ACROBiosystems Revenue Growth Rate in Recombinant Proteins Business (2021–2026)
 Figure 58. Sino Biological Revenue Growth Rate in Recombinant Proteins Business (2021–2026)
 Figure 59. Cytiva Revenue Growth Rate in Recombinant Proteins Business (2021–2026)
 Figure 60. Eurogentec Revenue Growth Rate in Recombinant Proteins Business (2021–2026)
 Figure 61. GenScript Biotech Corporation Revenue Growth Rate in Recombinant Proteins Business (2021–2026)
 Figure 62. Reprocell Revenue Growth Rate in Recombinant Proteins Business (2021–2026)
 Figure 63. BPS Bioscience Revenue Growth Rate in Recombinant Proteins Business (2021–2026)
 Figure 64. Abnova Corporation Revenue Growth Rate in Recombinant Proteins Business (2021–2026)
 Figure 65. ProSpec Tany TechnoGene Revenue Growth Rate in Recombinant Proteins Business (2021–2026)
 Figure 66. Ajinomoto Revenue Growth Rate in Recombinant Proteins Business (2021–2026)
 Figure 67. Bottom-up and Top-down Approaches for This Report
 Figure 68. Data Triangulation
 Figure 69. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Lukasiewicz Research Network